Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA.

Lippi, Giuseppe; Henry, Brandon M; Sanchis-Gomar, Fabian

Lippi, Giuseppe; Henry, Brandon M; Sanchis-Gomar, Fabian.

Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Henry BM; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Sanchis-Gomar F; Department of Physiology, University of Valencia, Valencia, Comunitat Valenciana, Spain fabian.sanchis@uv.es.

Eur J Hosp Pharm ; 29(3): e2, 2022 05.

Article in English | MEDLINE | ID: covidwho-1052323

Subject(s)

Anti-Anxiety Agents; COVID-19; Anti-Anxiety Agents/therapeutic use; Disease Outbreaks; Humans; SARS-CoV-2; United States/epidemiology

Keywords

COVID-19; mental health; primary health care; public health; social medicine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Anxiety Agents / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: North America Language: English Journal: Eur J Hosp Pharm Year: 2022 Document Type: Article Affiliation country: Ejhpharm-2020-002671

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google